Aimei Health Technology Co., Ltd. 10-K — AI Bull & Bear Analysis

The 10-K filing reveals a high-stakes race against time for Aimei Health. While the company has successfully navigated the technical requirements of a de-SPAC—including shareholder votes and SEC effectiveness—it remains hostage to the opaque timeline of the Chinese Securities Regulatory Commission. The tension between the bull case of a high-growth energy/health pivot and the bear case of imminent insolvency creates a binary outcome for investors. Ultimately, the filing highlights a significant shift in the company's risk profile. The massive redemption of shares has cleared the path for a leaner combined entity, but it has also stripped the company of the capital cushion typically seen in larger SPACs. Investors are now betting on a regulatory formality; if the CSRC notice arrives, the company unlocks a scalable PRC operator, but if it does not, the company faces a liquidation event where the trust may struggle to cover all obligations.